Author:
Inamoto Yoshihiro,Flowers Mary E.D.,Appelbaum Frederick R.,Carpenter Paul A.,Deeg H. Joachim,Furlong Terry,Kiem Hans-Peter,Mielcarek Marco,Nash Richard A.,Storb Rainer F.,Witherspoon Robert P.,Storer Barry E.,Martin Paul J.
Funder
National Institutes of Health, Department of Health and Human Services
Subject
Transplantation,Hematology
Reference20 articles.
1. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors;Nash;Blood,2000
2. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation;Ratanatharathorn;Blood,1998
3. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation;Hiraoka;Bone Marrow Transplant,2001
4. Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine;Horowitz;Biol Blood Marrow Transplant,1999
5. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2010. Available at: http://www.cibmtr.org.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献